The expression of AKAP12 is down-regulated in various cancers including colon cancer, childhood acute lymphoblastic leukemia and hepatocellular carcinoma, etc. Insulin receptor substrate 4 (IRS4), a cytoplasmic protein containing many potential phosphorylation sites, is overexpressed in NSCLC. Here, AKAP12 is linked to hepatocellular carcinoma.